Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigens

L. Lazaro-Olán, G. Mellado-Sánchez, J. García-Cordero, A. Escobar-Gutiérrez, L. Santos-Argumedo, B. Gutiérrez-Castañeda, L. Cedillo-Barrón

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

This study was undertaken to evaluate the feasibility of using recombinant dengue proteins to discriminate between acute dengue infections versus uninfected dengue samples. Dengue virus proteins E, NS1, NS3, and NS4B were cloned as fusion proteins and expressed in Escherichia coli. Recombinant products were tested in 100 serum samples obtained from acute dengue fever cases collected from 3 states of Mexico where dengue is endemic. Sera from 75 healthy individuals living in nonendemic areas for dengue were used as a control group. In sera from the dengue patients group, antibody responses to E protein were demonstrated in 91 of cases and NS1 protein was recognized to various extents (99) within the first 7 days of infection. The antibody responses to NS3 and NS4B were frequently of low magnitude. Consistent negative antibody responses to all proteins were found in sera from the control group. These data suggest that the glutathione-S-transferase (GST)-dengue fusion proteins may be feasible antigens for a sensitive and specific serological assay.

Original languageEnglish
Pages (from-to)69-79
Number of pages11
JournalVector-Borne and Zoonotic Diseases
Volume8
Issue number1
DOIs
StatePublished - 1 Feb 2008

Keywords

  • Antibodies
  • Dengue antigens
  • Dengue serology
  • Dengue virus

Fingerprint

Dive into the research topics of 'Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigens'. Together they form a unique fingerprint.

Cite this